Ardelyx (NASDAQ: ARDX) has added Susan Rodriguez to its C suite as the company’s first chief commercial officer. Rodriguez was most recently president of the branded division of Tolmar, a merged entity created from Tolmar Pharmaceuticals and its sister companies. She previously served as the founding CEO of Tolmar Pharma. Before Tolmar Rodriguez held various roles at Abbott Laboratories (NYSE: ABT), where during her tenure she played a key role in 11 global product launches.

Fremont, CA-based Ardelyx, which is developing treatments for patients with kidney and cardiovascular diseases, this year plans to request FDA review of tenapanor, an… Read more »